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Abstract: Herein, we report the synthesis of 5,12-dihydropyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]-
diquinoline-6,14(5H,12H)diones, 2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)-1,4-diphenyl-butane-1,4-
diones and 4-(benzo-[d]oxazol-2-yl)-3-hydroxy-1H-[4,5]oxazolo[3,2-a]pyridine-1-one. The new candidates
were synthesized and identified by different spectroscopic techniques, and X-ray crystallography.
Keywords: 6,7-Disubstituted-4-hydroxy-quinoline-2-ones; 2,3-dichloropyrazine; ANRORC process
bis-pyrazinofuro-quinoline; 1,4-diphenylbutane-1,4-diones; NMR; X-ray
1. Instruction
Furoquinolones are an interesting class of 2-quinolones and representative examples of them
as naturally occurring compounds are shown in compounds such as Skimmianine and γ-Fagarine
(Figure 1), both compounds that have been found to have anti-cancer activity [1,2]. It was reported
that furopyrazine scaffold was functionalized with an amino- and a carboxy-terminus resulting in a
conformationally restricted dipeptidomimetic scaffold [3].
Alkyl quinolones (AQs) are a species-specific class of quorum-sensing molecule that have been
described in P. aeruginosa [4,5] and related bacteria including P. putida and Burkholderia spp. [6]. More
than 55 distinct AQs (i.e., an example is shown in Figure 1 and assigned as PQS) are produced through
the PqsABCDE (Figure 1) biosynthetic pathway in P. aeruginosa, with the majority of the diversity
arising from unsaturation, different alkyl chain lengths, and modification of the ring-substituted
nitrogen [6,7]. An insight into the evolutionary basis of AQ diversity has emerged from Burkholderia
thailandensis where AQ analogues (i.e., two examples assigned as HHQ and HQNP and are shown in
Figure 1) are shown to act synergistically to inhibit bacterial growth [8,9].
Quinolones have been also developed for clinical use in humans [10]. These antibiotics exert their
effect by inhibition of two type II topoisomerase enzymes, DNA gyrase and topoisomerase IV [11]. DNA
topoisomerases are found in both eukaryotic and prokaryotic cells and are a target for chemotherapeutic
intervention in anti-bacterial and anti-cancer therapies [12]. In a recent publication [13], the synthesis
of the Zwitter-ionic 4-hydroxycoumarin derivatives was reported, through a unique reaction of
4-hydroxycoumarins with p-benzoquinone and pyridine in aqueous acetone.
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Figure 1. The structures of Skimmianine, γ-Fagarine, an example of QS of PqsABCDE biosynthesis 
and two examples of quinolone analogues as antibacterial reagents. 
Figure 2 indicates what we previously synthesized of 4-hydroxy-2-quinolone. An example, 
2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinic acid derivatives I, were obtained by 
one-pot reaction of one equivalent of aromatic amines with two equivalents of diethyl malonate in 
diphenyl ether and catalyzed with triethylamine [14]. On reacting four equivalents of 
4-hydroxyquinolin-2(1H)-ones with one equivalent of acenaphthoquinone in absolute ethanol, 
containing catalytic Et3N, the reaction gave acenaphthylene-1,1,2,2-tetrayl-tetrakis- 
(4-hydroxyquinolin-2(1H)-ones) (II, [15]. We also reported that quinoline-2,4-diones reacted with 
2-(2-oxo-1,2-dihydroindol-3-ylidene)malononitrile in pyridine to give spiro(indoline-3,4′-pyrano- 
[3,2-c]quinoline)-3′-carbonitriles (III, [16]. The same target materials of 2-quinolones reacted with 
diethyl acetylenedicarboxylate in absolute ethanol, containing catalytic triethylamine, to give 
pyrano[3,2-c]quinoline-4-carboxylates (IV, [17]. We have recently reported that a class of 
1,2,3-triazoles derived by 2-quinolone (V, [18]) has been synthesized, via Cu-catalyzed [3 + 
2]cycloadditions (Meldal–Sharpless ‘click’-reactions) of 4-azidoquinolin-2(1H)-ones with ethyl 
propiolate [18]. We also synthesized fused naphthofuro[3,2-c]quinoline-6,7,12-triones VI, and 
pyrano[3,2-c]quinoline-6,7,8,13-tetraones, VII that have shown potential as ERK inhibitors [19]. 
Whereas syntheses of 
bis(6-substituted-4-hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl)-naphthalene-1,4-diones VIII and 
substituted N-(alkyl)bis-quinolinone triethyl-ammonium salts VIV, were explored as candidates for 
extracellular signal-regulated kinases 1/2 (ERK1/2) having antineoplastic activity [20]. 
The aforementioned interesting pharmaceutical and biological activities of 
4-hydroxy-2-quinolones make them valuable in drug research and development. Hence, many 
publications have recently dealt with their synthetic analogous and the synthesis of their 
heteroannelated derivatives. Consequently, we have found that it is of importance to shed new light 
on these interesting heterocycles. Accordingly, the reactivity of 1,6-disubstituted-4-hydroxy- 
quinolinones 1a–f was tested towards 2,3-dichloropyrazine (2) and (E)-dibenzoylethene (4). 
Figure 1. The structures of Skimmianine, γ-Fagarine, an example of QS of PqsABCDE biosynthesis and
two examples of quinolone analogues as antibacterial reagents.
Figure 2 indicates what we previously synthesized of 4-hydroxy-2-quinolone. An example,
2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroqu nolin-3-yl)succinic acid derivatives I, were obtained by o e-pot
reaction of one equivalent of aromatic amines with two equivalents of diethyl malonate in diphenyl ether
and catalyzed with triethylamine [14]. On reacting four equivalents of 4-hydroxyquinolin-2(1H)-ones
with one equivalent of acenaphthoquinone in absolute ethanol, containing catalytic Et3N, the
reaction gave acenaphthylene-1,1,2,2-tetrayl-tetrakis- (4-hydroxyquinolin-2(1H)-ones) (II, [15]. We also
reported that quinoline-2,4-diones reacted with 2-(2-oxo-1,2-dihydroindol-3-ylidene)malononitrile
in pyridine to give spiro(indoline-3,4′-pyrano- [3,2-c]quinoline)-3′-carbonitriles (III, [16]. The
same target materials of 2-quinolones reacted with diethyl acetylenedicarboxylate in absolute
ethanol, containing catalytic triethylamine, to give pyrano [3,2-c]quinoline-4-carboxylates (IV, [17].
We have recently reported that a class of 1,2,3-triazoles derived by 2-quinolone (V, [18]) has
been synth sized, via Cu-catalyzed [3 + 2]cycloadditions (Meldal–Sharpless ‘click’-react ons) f
4-azidoquinolin-2(1H)-ones with ethyl propiolate [18]. We also synth sized fused naphthofuro[3,2-c]
quinoline-6,7,12-triones VI, and pyrano[3,2-c]quinoline-6,7,8,13-tetraones, VII that have shown
potential as ERK inhibitors [19]. Whereas syntheses of bis(6-substituted-4-hydroxy-2-oxo-1,2-
dihydro-quinolin-3-yl)-naphthalene-1,4-diones VIII and substituted N-(alkyl)bis-quinolinone
triethyl-ammonium salts VIV, were explored as candidates for extracellular signal-regulated kinases
1/2 (ERK1/2) having antineoplastic activity [20].
The aforementioned interesting pharmaceutical and biological activities of 4-hydroxy-2-quinolones
make them valuable in drug research and development. Hence, many publications have recently dealt
with their synthetic analogous and the synthesis of their heteroannelated derivatives. Consequently, we
have found that it is of importance to shed new light on these interesting heterocycles. Accordingly, the
reactivity of 1,6-disubstituted-4-hydroxy- quinolinones 1a–f w s tested towards 2,3-dichloropyraz ne
(2) and (E)-dibenzoylethene (4).
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Figure 2. Structures of compounds that previously reported (Reproduced with permission from [14–
20]). 
2. Results and Discussion 
Upon mixing equivalent amounts of 2,3-dichloropyrazine (2) and 6,7-disubstituted-4-hydroxy- 
quinolin-2-ones 1a–f, followed by refluxing in dimethylformamide (DMF) and catalyzed by 
triethylamine (Et3N), 3a–f were obtained as single products (Scheme 1). Structure elucidation of 
compounds 3a–f was carried out by infrared (IR), 1H-nuclear magnetic resonance (NMR), 13C-NMR 
and mass spectrometry, as well as elemental analyses. 
Scheme 1. Reactions of 2-quinolinones 1a–f with 2,3-dichloropyrazine (2) and 1,2-(E)- 
dibenzoylethene (4). 
The reaction products were identified as pyrazino[2′,3′:4,5]furo[3,2-c]quinolin-6(5H)-ones 3a–f. 
The IR spectra showed absorption for C=N at ν = 1630–1600 cm−1. Besides the NH stretching 
appeared as broad peaks at ν = 3320–3260 cm−1. As for example, the elemental analysis and mass 
Figure 2. Structures of compounds that previously reported (Reproduced with permission from [14–20]).
2. Results and Discussion
Upon mixing equivalent amounts of 2,3-dichloropyrazine (2) and 6,7-disubstituted-4-hydroxy-
quinolin-2-ones 1a–f, followed by refluxing in dimethylformamide (DMF) an catalyzed by
triethylamine (Et3N), 3a–f were obtained as single products (Scheme 1). Structure elucidation
of compounds 3a–f was carried out by infrared (IR), 1H-nuclear magnetic resonance (NMR), 13C-NMR
and mass spectrometry, as well as elemental analyses.
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Scheme 1. Reactions of 2-quinolinones 1a–f with 2,3-dichloropyrazine (2) and 1,2-(E)-dibenzoylethene (4).
The reaction products were identified as pyrazino[2′,3′:4,5]furo[3,2-c]quinolin-6(5H)-ones 3a–f.
The IR spectra showed absorption for C=N at ν = 1630–1600 cm−1. Besides the NH stretching appeared
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as broad peaks at ν = 3320–3260 cm−1. As for example, the elemental analysis and mass spectra proved
its molecular formula of 3a as C22H10N4O4, which indicated addition of two moles of 1a to two moles
of 2 accompanied with elimination of four moles of HCl. The expected structure 7 was ruled out, since
1H-NMR spectrum did not show the expected azomethine protons (Figure 3). Either the syn-structure
3a′ or the anti-form has to show symmetric carbon signals in 13C-NMR spectrum. Most assigned
carbons are the two carbonyl and C=N carbons which appeared at δ = 167.1, 165.2 and 160.8, 160.2
ppm. In Spartan 18: geometries program [21] optimized at the 6-31G* level with B3LYP the energy
difference between calculated Anti-3a: and Syn-3a’ shows that Anti-3a is more stable by 2.029 kcal/mol.
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would seem to be two-fold displacement followed by two-fold oxi ative cyclization, presumably by air.
If the chlorides are the leaving groups, only one can undergo ipso substitution: the other nucleophile
must attack the other side of the ring. The SNAr process can give ipso substitution only, but the
ANRORC process can proceed at the pseudo-meta position (Scheme 2). We are therefore led to propose
the mechanism for formation of 3, shown in Scheme 3. Here “Nu:-“ is 1, attacking via its α-carbon.
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Surprisingly, on attempting to prepare 4-hydroxy-2-quinolone 1g from 2-hydroxyaniline (9)
and diethyl malonate (10) in polyphosphoric acid (PPA) according to the procedure described in
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reference [28], compound 11 was obtained in 80% yield (Scheme 4). Similarly, reaction of 11 with 4
under the same conditions produced compound 12 in 85% yield.
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Scheme 5. Proposed rationale for formation of 11.
The NMR spectroscopic data of compound 12 (detailed in full in Table S2; see Supplementary
Materials) show a broad OH, two ets of phenyl signals, and eight other pr ton signals, although
most of th benzoxazole signals cannot be solved fully. The prot s on sp3 carbons are distinctive
at δ = 5.55, 4.36, and 2.85 ppm; the latter two are assigned as H-2b based on their geminal coupling
constant of 17 Hz. The ttached carbons appe r at δ = 39.5 (C-2 ) and 37.35 ppm (C-2b). The C-2a
gives Heteronuclear Multiple Bond Correlation (HMBC) correlation with a carbon at δ = 156.92 ppm,
which could be either C-1 or C-3, and is assigned based on chemical shift as C-1. Correlations within
the benzoyl groups are straightforward. The str cture of compound 12 was confirmed by X-ray
crystallography (Figure 6).
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Figure 6. Molecular structure of compound 12 assigned as 2-(4-hydroxy-6-methyl-2-oxo-1,2-
dihydroquinolin-3-yl)-1,4-diphenylbutane-1,4-dione.
3. Experimental
3.1. Material and Methods
Melting points were taken in open capillaries on a Gallenkamp melting point apparatus
(Weiss-Gallenkamp, Loughborough, UK) and are uncorrected. The IR spectra were recorded from
potassium bromide disks with a Fourier Transform Infrared (FT-IR) device (Mettler-Toledo GmbH,
Giessen, Germany), Minia University. Elemental analyses were carried out at the Perkin-Elmer out
with Elementar 306 (Perkin-Elmer, Walluf, Germany). NMR data were recorded on Bruker AM 400 or
AV400 spectrometers (Bruker, Karlsruhe, Germany), at 400 Hz for 1H and 100 MHz for 13C. Chemical
shifts were reported in ppm from tetramethylsilane using solvent resonance in DMSO-d6 solutions
as the internal standard. Coupli g constants are stated in Hz. Correlations were established using
1H-1H COSY, and 1H-13C and 1H-15N heteronuclear single quantum coherence (HSQC) and HMBC
experiments. Mass spectra were recorded on a Finnigan MAT 312 instrument Fab 70 eV (T ermo
Fisher, Bremen, Germany), Institute of Organic Chemistry, Karlsruhe University, Karlsruhe, Germany.
Thin Layer C ro atography (TLC) was performed on analytical Merck 9385 silica aluminum sheets
( ieselgel 60) with Pf254 indicator; TLCs were viewed at λ max = 254 nm. Elemental analyses for C, H,
N were carried out with Elementar 306.
3.2. Starting Materials
1,6-Disubstituted-quinoline-2,4-(1H,3H)-diones 1a–f were prepared according to the
literature [28,29]. 2,3-Dichloropyrazine (2) and (E)-1,2-dibenzoylethene (4) (Aldrich, Munich, Germany)
were used as received.
3.2.1. Reaction of 1a–f with 2,3-Dichloropyrazine (2)
A suspension of 1,6-disubstituted quinoline-2,4-(1H,3H)-diones 1a–f (2 mmol) in 10 mL
dimethylformamide (DMF) was added to a solution of (E)-1,4-diphenylbut-2-ene-1,4-dione (2, 0.148 g,
1 mmol) in 15 mL DMF and 0.5 mL of triethylamine. The reaction mixture was gently refluxed for
20–25 h, until the reactants had disappeared (monitored by TLC). The resulting precipitates of 3a–f
which were obtained cold were filtered off and dried. The precipitates were recrystallized from the
stated solvents.
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3.2.2. 5,12-Dihydropyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)-Dione (3a)
Buff crystals (DMF/EtOH), yield: 0.256 g (65%), mp = 330–332 ◦C; IR (KBr): ν = 3220 (NH), 1660
(CO), 1606 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.11 (s, 2H, NH), 7.89–7.85 (m, 2H,
Ar-H), 7.52–7.48 (m, 2H, Ar-H), 7.35–7.32 (m, 2H, Ar-H), 7.23–7.19 ppm (m, 2H, Ar-H); 13C-NMR (100
MHz, DMSO-d6): δ = 165.2 (C=O), 160.2 (C=N), 153.4, 139.4, 138.4, 130.7 (Ar-C), 125.9, 128.4, 122.8,
115.7 (Ar-CH), 109.5 ppm (Ar-C); MS (Fab, 70 eV, %): m/z = 394 (M+, 27). Anal. Calcd. for C22H10N4O4
(394.35): C, 67.01; H, 2.56; N, 14.21. Found: C, 66.90; H, 2.70; N, 14.30.
3.2.3. 2,10-Dichloro-5,12-Dihydropyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]-Diquinoline-6,14(5H,12H)-
Dione (3b)
Buff crystals (DMF/EtOH), yield: 0.310 g (67%), mp = 320–322 ◦C, IR (KBr): ν = 3210 (NH),
1665 (CO), 1612 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.07 (s, 2H, 2NH), 7.98 (d, 2H,
J = 0.7 Hz, Ar-2CH), 7.38–7.20 ppm (m, 4H, Ar-H); 13C-NMR (100 MHz, DMSO-d6): δ = 167.2 (C=O),
160.2 (C=N), 154.4, 139.0, 138.2 (Ar-C), 128.1, 126.9, 125.4, 120.0 (Ar-2H), 118.0, 109.4 ppm (Ar-C); MS
(Fab, 70 eV,%): m/z = 464/468 (M+, 60/30), 443 (25), 371 (22), 137 (50). Anal. Calcd. for C22H8Cl2N4O4
(463.23): C, 57.04; H, 1.74; N, 12.10. Found: C, 57.20; H, 1.70; N, 12.20.
3.2.4. 3,11-Dichloro-5,12-Dihydropyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)-
Dione (3c)
Buff crystals (DMF), yield: 0.295 g (64%), mp = 350–352 ◦C; IR (KBr): ν = 3230 (NH), 1663 (CO),
1620 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.11 (s, 2H, 2NH), 7.95 (d, 2H, J = 1.2 Hz,
Ar-2CH), 7.45–7.41 ppm (m, 4H, Ar-H); 13C-NMR (100 MHz, DMSO-d6): δ = 167.0 (C=O), 160.4 (C=N),
152.0, 138.7, 138.0, 130.6 (Ar-C), 127.0, 124.9, 122.2 (Ar-CH), 120.0, 108.2 ppm (Ar-C); MS (Fab, 70 eV,%):
m/z = 464/468 (M+1, 32/64), 462 (36), 443 (32), 371 (24), 137 (54). Anal. Calcd. for C22H8Cl2N4O4 (463.23):
C, 57.04; H, 1.74; N, 12.10. Found: C, 57.00; H, 1.80; N, 12.15.
3.2.5. 2,10-Dibromo-5,12-Dihydropyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)-
Dione (3d)
Pale yellow crystals (DMF), yield: 0.390 g (70%), mp = 310–312 ◦C; IR (KBr): ν = 3230 (NH),
1667 (CO), 1610 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.43 (s, 2H, 2NH), 8.01–7.96 (m,
2H, Ar-CH), 7.75–7.72 (m, 2H, Ar-H), 7.38–7.36 ppm (m, 2H, Ar-H); 13C-NMR (100 MHz, DMSO-d6):
δ = 166.8 (C=O), 160.4 (C=N), 150.8, 141.0, 135.5, 131.4 (Ar-C), 128.6, 127.8, 124.2 (Ar-CH), 118.2, 103.0
ppm (Ar-C); MS (Fab, 70 eV, %): m/z = 552/556 (M+, 34/58), 552 (100), 371 (22), 137 (50). Anal. Calcd. for
C22H8B2N4O4 (552.14): C, 47.86; H, 1.46; N, 10.15. Found: C, 47.90; H, 1.56; N, 10.25.
3.2.6. 5,12-Dihydro-3,11-Dimethylpyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)-
Dione (3e)
Brown crystals (DMF/CH3OH), yield: 0.280 g (66%), mp = 276–278 ◦C (decomp.), IR (KBr):
ν = 3222 (NH), 1660 (CO), 1620 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.15 (s, 2H, 2NH),
7.92 (d, 2H, J = 0.8 Hz, Ar-H), 7.45–7.30 (m, 4H, Ar-H), 2.16 ppm (s, 6H, 2CH3); 13C-NMR (100 MHz,
DMSO-d6): δ = 166.8 (C=O), 159.8 (C=N), 150.0 (C-O), 138.0, 137.4, 130.0, 128.2 (Ar-C), 127.8, 127.2
(Ar-CH), 125.5, 110.4 (Ar-C), 20.4 ppm (CH3); MS (Fab, 70 eV, %): m/z 422 = (M+, 28), 406 (24), 370 (20),
137 (48). Anal. Calcd. for C24H14Cl2N4O4 (422.40): C, 68.24; H, 3.34; N, 13.26. Found: C, 68.30; H, 3.45;
N, 13.35.
3.2.7. 5,12-Dihydro-2,10-Dimethylpyrazino[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)-
Dione (3f)
Brown crystals (DMF/CH3CN), yield: 0.290 g (68%), mp 300–302 ◦C; IR (KBr): ν = 3225 (NH),
1665 (CO), 1630 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 12.20 (s, 1H, 2NH), 7.84 (d, 2H,
J = 1.2 Hz, Ar-2CH), 7.42–7.35 (m, 4H, Ar-H), 2.18 ppm (s, 6H, 2CH3); 13C-NMR (100 MHz, DMSO-d6):
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δ = 166.2 (C=O), 160.0 (C=N), 152.7 (C-O), 139.6 (Ar-CH3), 135.4, 130.4, 128.6 (Ar-C), 128.0, 127.0, 126.2
(Ar-CH), 110.4 (Ar-C), 20.2 ppm (CH3); MS (Fab, 70 eV, %): m/z = 422 (M+, 28), 406 (24), 370 (20), 137
(48). Anal. Calcd. for C24H14Cl2N4O4 (422.40): C, 68.24; H, 3.34; N, 13.26. Found: C, 68.20; H, 3.50;
N, 13.32.
3.3. Reaction of 1a–f with (E)-1,2-Dibenzoylethene (4)
A mixture of 1a–f (1 mmol) and (E)-1,2-dibenzoylethene (4) (0.246 g, 1 mmol) in pyridine (50 mL)
and 0.5 mL of triethylamine, was gently refluxed for 10–15 h, until the reactants had disappeared
(monitored by TLC). The resulting precipitates of 6a–f, which obtained on cold were filtered off and
dried. The precipitates were recrystallized from the stated solvents.
3.3.1. 2-(4-Hydroxy-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6a)
Yellow crystals (DMF/EtOH), yield: 0.300 g (75%), mp = 325–327 ◦C, IR (KBr): ν = 3220 (NH),
3023 (Ar-CH), 3000 (Aliph-CH), 1698, 1673 (CO), 1631 (Ar-C=N), 1590 cm−1 (C=C); 1H-NMR (400
MHz, DMSO-d6): δ = 8.01 (d, J = 7.5 Hz, 2H; H-o’), 7.92 (d, J = 8.0 Hz, 1H; H-5), 7.83 (d, J = 7.5 Hz, 2H;
H-o), 7.65 (t, J = 7.3 Hz, 1H; H-p’), 7.55 (“t”, J = 7.6 Hz, 2H; H-m’), 7.48 (t, J = 7.5 Hz, 1H; H-p), 7.46 (“t”,
J = 7.8 Hz, 1H; H-7), 7.38 (“t”, J = 7.5 Hz, 2H; H-m), 7.23 (d, J = 8.1 Hz, 1H; H-8), 7.14 (“t”, J = 7.6 Hz,
1H; H-6), 5.47 (dd, J = 9.6, 2.4 Hz, 1H; H-α), 4.21 (dd, J = 17.3, 9.8 Hz, 1H; H-α’), 2.82 ppm (dd, J = 17.2,
2.5 Hz, 1H; H-α’). 15N-NMR: 142.95 ppm (N-1). 13C-NMR (100 MHz, DMSO-d6): δ = 198.48 (C-β),
198.31 (C-β’), 162.36 (C-2), 158.85 (C-4), 137.81, 137.01, 136.66 (C-i, i’, 8a), 132.91 (C-p’), 132.29 (C-p),
130.44 (C-7), 128.63 (C-m’), 128.21 (C-m), 127.83 (C-o’), 127.36 (C-o), 122.65 (C-5), 121.08 (C-6), 115.17,
115.06 (C-4a, 8), 111.47 (C-3), 40.41 (C-α), 37.44 ppm (C-α’). MS (Fab, 70 eV, %): m/z = 397 (M+, 100).
Anal. Calcd. for C25H19NO4 (397.43): C, 75.55; H, 4.82; N, 3.52. Found: C, 75.70; H, 4.90; N, 3.62.
3.3.2. 2-(6-Chloro-4-Hydroxy-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6b)
Pale yellow crystals (DMF/CH3CN), yield: 0.310 g (72%), mp = 315–317 ◦C, IR (KBr): ν = 3230
(NH), 3010 (Ar-CH), 2803 (Aliph-CH), 1693, 1644 (CO), 1604 cm−1 (Ar-C=N); 1H-NMR (400 MHz,
DMSO-d6): δ = 12.30 (s, 1H, OH), 11.50 (s, 1H, NH), 8.00 (d, 1H, J = 7.6 Hz, Ar-H), 7.90 (d, 1H,
J = 7.98 Hz, Ar-H), 7.82 (d, 1H, J = 8.0 Hz, Ar-H), 7.54–7.50 (m, 5H, Ar-H), 7.30 (t, 2H, J = 7.8 Hz, Ar-H),
7.24–7.10 (m, 3H, Ar-H), 5.50 (dd, 1H, J = 10, 2.3 Hz, CH-α), 4.18 (dd, 1H, J = 17.0, 9.9 Hz, CH2-α), 2.80
(dd, 1H, J = 17.0, 2.6 Hz, CH2-α’); 13C-NMR (100 MHz, DMSO-d6): δ = 198.5, 198.3, 164.0 (CO), 158.0
(Ar-C), 136.8 (Ar-3C), 132.6, 132.1 (Ar-CH-p), 130.3 (Ar-2CH), 128.5, 128.0 (Ar-2CH-m), 127.8, 127.6
(Ar-2CH-o), 123.0 (Ar-CH-5), 120.0 (Ar-C-Cl), 115.2, 110.0 (Ar-C), 40.5 (CH2), 37.2 ppm (CH). MS (Fab,
70 eV, %): m/z = 431/433 (M+2, 23), 413 (17), 309 (14), 148 (37), 104 (100). Anal. Calcd. for C25H18ClNO4
(431.87): C, 69.53; H, 4.20; N, 3.24. Found: C, 69.62; H, 4.30; N, 3.32.
3.3.3. 2-(7-Chloro-4-Hydroxy-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6c)
White crystals (DMF/CH3CN), yield: 0.302 g (70%), mp = 340–342 ◦C, IR (KBr): ν = 3225 (NH),
3030 (Ar-CH), 2820 (Aliph-CH), 1690, 1650 (CO), 1612 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6):
δ = 12.10 (s, 1H, OH), 11.40 (s, 1H, NH), 7.98 (d, 1H, J = 7.8 Hz, Ar-H), 7.80 (d, 1H, J = 8.0 Hz,
Ar-H), 7.60–7.50 (m, 6H, Ar-H), 7.20 (t, 2H, J = 7.8 Hz, Ar-H), 7.18–7.12 (m, 3H, Ar-H), 5.45 (dd, 1H,
J = 10, 2.3 Hz, CH-α), 4.20 (dd, 1H, J = 17.0, 9.9 Hz, CH2-α), 2.85 ppm (dd, 1H, J = 17.0, 2.6 Hz,
CH2-α’); 13C-NMR (100 MHz, DMSO-d6): δ = 198.4, 198.1, 162.4 (CO), 157.8 (Ar-C), 138.7, 137.0,
136.6 (Ar-C), 134.9, 132.9 (Ar-CH-p), 132.4 (Ar-2CH), 129.8, 128.9 (Ar-2CH-m), 128.6, 128.5 (Ar-2CH-o),
122.6 (Ar-CH-5), 119.5 (Ar-C-Cl), 121.3, 114.3 (Ar-C), 40.6 (CH2), 39.0 ppm (CH). MS (Fab, 70 eV, %):
m/z = 431/433 (36/60), 413 (17), 309 (14), 148 (37), 104 (100). Anal. Calcd. for C25H18ClNO4 (431.87): C,
69.53; H, 4.20; N, 3.24. Found: C, 69.70; H, 4.15; N, 3.28.
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3.3.4. 2-(6-Bromo-4-Hydroxy-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6d)
Pale yellow crystals (DMF/CH3OH), yield: 0.365 g (76%), mp = 348–350 ◦C, IR (KBr): ν = 3230
(NH), 3010 (Ar-CH), 2803 (Aliph-CH), 1693, 1644 (CO), 1604 cm−1 (Ar-C=N); 1H-NMR (400 MHz,
DMSO-d6): δ = 12.30 (s, 1H, OH), 11.50 (s, 1H, NH), 8.00 (d, 1H, J = 7.6 Hz, Ar-H), 7.90 (d, 1H,
J = 7.98 Hz, Ar-H), 7.82 (d, 1H, J = 8.0 Hz, Ar-H), 7.54–7.50 (m, 5H, Ar-H), 7.30 (t, 2H, J = 7.8 Hz, Ar-H),
7.24–7.10 (m, 3H, Ar-H), 5.50 (dd, 1H, J = 10, 2.3 Hz, CH-α), 4.18 (dd, 1H, J = 17.0, 9.9 Hz, CH2-α), 2.80
ppm (dd, 1H, J = 17.0, 2.6 Hz, CH2-α’); 13C-NMR (100 MHz, DMSO-d6): δ = 198.2, 197.6, 165.0 (CO),
158.2 (Ar-C), 138.0, 137.4, 133.0 (Ar-C), 132.4, 132.0 (Ar-CH-p), 130.0 (Ar-2CH), 128.8, 127.8 (Ar-2CH-m),
127.5, 127.0 (Ar-2CH-o), 122.6 (Ar-CH-5), 124.0 (Ar-C-Br), 115.0, 110.0 (Ar-C), 40.6 (CH2), 37.0 ppm
(CH). MS (Fab, 70 eV, %): m/z = 475/477(32/58), 442 (18), 442 (12), 390 (6), 369 (10), 358 (12), 340 (17), 328
(24), 153 (100). Anal. Calcd. for C25H18BrNO4 (475.33): C, 63.04; H, 3.81; N, 2.94. Found: C, 62.96; H,
3.70; N, 3.08.
3.3.5. 2-(4-Hydroxy-7-Methyl-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6e)
Pale yellow crystals (DMF/EtOH), yield: 0.320 g (77%), mp 352–354 ◦C; IR (KBr): ν = 3230 (NH),
3010 (Ar-CH), 2890 (Aliph-CH), 1695, 1660 (CO), 1620 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6):
δ = 11.35 (s, 1H; NH), 10.77 (b, 1H; OH), 8.01 (dd, 2H, J = 8.5, 1.3 Hz; H-o’), 7.81 (d, 2H, J = 7.3 Hz; H-o),
7.73 (bs, 1H; H-5), 7.65 (t, 1H, J = 7.4 Hz; H-p’), 7.55 (“t”, 2H, J = 7.6 Hz; H-m’), 7.47 (t, 1H, J = 7.3 Hz;
H-p), 7.38 (“t”, 2H, J = 7.6 Hz; H-m), 7.29 (dd, 1H, J = 8.4, 1.3 Hz; H-7), 7.14 (d, 1H, J = 8.3 Hz; H-8),
5.46 (dd, 1H, J = 9.7, 3.1 Hz; H-α), 4.19 (dd, 1H, J = 17.3, 9.8 Hz; H-α’), 2.82 (dd, 1H, J = 17.3, 3.1 Hz;
H-α’), 2.31 ppm (s, 3H; H-6a); 13C-NMR (100 MHz, DMSO-d6): δ = 198.46, 198.31 (C-β,β’), 162.21 (C-2),
158.27 (C-4), 137.81, 137.01 (C-i,i’), 136.66 (C-8a), 132.92 (C-p’), 132.26 (C-p), 131.66 (C-7), 130.10 (C-6),
128.63 (C-m’), 128.19 (C-m), 127.83 (C-o’), 127.34 (C-o), 122.13 (C-5), 115.12 (C-8), 114.75 (C-4a), 111.68
(C-3), 40.46 (C-α), 37.45 (C-α’), 20.59 ppm (C-6a); 15N-NMR (40.55 MHz, DMSO-d6): δ = 142.1 ppm
(N-1). MS (Fab, 70 eV, %): m/z = 411 = (M+, 40), 393 (16), 153 (100). Anal. Calcd. for C26H21NO4 (411.46):
C, 75.90; H, 5.14; N, 3.40. Found: C, 76.10; H, 5.24; N, 3.50.
3.3.6. 2-(4-Hydroxy-6-Methyl-2-oxo-1,2-Dihydroquinolin-3-yl)-1,4-Diphenylbutane-1,4-Dione (6f)
Yellow crystals (DMF/H2O), yield: 0.320 g (77%), mp = 282–284 ◦C, IR (KBr): ν = 3226 (NH), 3012
(Ar-CH), 2860 (Aliph-CH), 1690, 1656 (CO), 1610 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6):
δ = 12.10 (s, 1H, OH), 11.70 (s, 1H, NH), 7.98 (d, 1H, J = 7.7 Hz, Ar-H), 7.86 (d, 1H, J = 8.00 Hz, Ar-H),
7.80 (d, 1H, J = 7.8 Hz, Ar-H), 7.62-7.55 (m, 5H, Ar-H), 7.28 (t, 2H, J = 8.0 Hz, Ar-H), 7.30–7.24 (m, 3H,
Ar-H), 5.48 (dd, 1H, J = 10.0, 2.4 Hz, CH-α), 4.22 (dd, 1H, J = 17.0, 9.9 Hz, CH2-α), 2.82 (dd, 1H, J = 17.0,
2.6 Hz, CH2-α’), 2.20 ppm (s, 3H, CH3); 13C-NMR (100 MHz, DMSO-d6): δ = 198.0, 197.6, 163.0 (CO),
158.2 (Ar-C), 136.8, 135.4, 135.0 (Ar-C), 132.4, 132.0 (Ar-CH-p), 131.5, 130.0 (Ar-2CH-m), 128.9 (Ar-2CH),
127.8, 127.6 (Ar-2CH-o), 123.0 (Ar-CH-5), 120.0 (Ar-C-Cl), 115.2, 110.0 (Ar-C), 40.5 (CH2), 37.2 (CH),
21.2 ppm (CH3). MS (Fab, 70 eV, %): m/z = 411 (M+, 42), 393 (10), 153 (100). Anal. Calcd. for C26H21NO4
(411.46): C, 75.90; H, 5.14; N, 3.40. Found: C, 76.00; H, 5.22; N, 3.30.
3.3.7. 4-(Benzo[d]oxazol-2-yl)-3-Hydroxy-1H-Benzo[4,5]oxazolo[3,2-a]pyridine-1-one (11)
Buff crystals (DMF/CH3CN), yield: 0.255 g (80%), mp = 270–272 ◦C, IR (KBr): ν = 3030 (Ar-CH),
2860 (Aliph-CH), 1656 (CO), 1610 cm−1 (Ar-C=N). 1H-NMR (400 MHz, DMSO-d6): δ = 12.90 (s, 1H,
OH), 8.40 (dd, 1H, J = 7.0 Hz, Ar-H), 8.00 (d, 2H, J = 7.3 Hz; Ar-H), 7.96 (m, 2H, J = 7.6 Hz; Ar-H), 7.92
(m, 1H, J = 8.2 Hz; Ar-H), 7.84 (m; 1H, Ar-H), 7.80 (m; 1H, Ar-H), 5.55 ppm (dd, 1H, J 7.5, 1.2 Hz; Ar-H).
13C-NMR (100 MHz, DMSO-d6): δ = 165.4 (CO), 160.0 (CH) 153.0, 149.8 (Ar-2C) 148.3, 147.0 (Ar-2C)
138.3 (Ar-C) 126.6, 126.3 (Ar-2CH) 124.41, 125.31, 124.24 (Ar-3CH) 123.7 (Ar-CH), 118.5, 116.2 (Ar-2C),
111.4 (Ar-CH), 110.2 (Ar-CH), 104.2 ppm (Ar-CH). MS (Fab, 70 eV, %): m/z = 318 (M+, 100), 200 (30), 118
(75). Anal. Calcd. for C18H10N2O4 (318.29): C, 67.93; H, 3.17; N, 8.80. Found: C, 68.10; H, 3.25; N, 8.90.
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3.3.8. (4-(Benzo[d]oxazol-2-yl)-3-Hydroxy-1-oxo-1H-Benzo[4,5]oxazolo[3,2-a]pyridin-2-yl)-
1,4-Diphenylbutane-1,4-Dione (12)
White crystals (DMF/EtOH), yield: 0.472 g (85%), mp = 278–280 ◦C, IR (KBr): ν = 3010 (Ar-CH),
2895 (Aliph-CH), 1665 (CO), 1620 cm−1 (Ar-C=N); 1H-NMR (400 MHz, DMSO-d6): δ = 13.16 (b, 1H;
OH), 8.45 (dd, 1H, J = 7.0, 2.0 Hz; H-9)., 8.03 (d, 2H, J = 7.3 Hz; H-o/o’), 7.95 (d, 2H, J = 7.6 Hz; H-o’/o),
7.90 (bd, 1H, J = 8.2 Hz; H-6), 7.86 (m, 1H; H-7’), 7.80 (h, 1H; H-4’), 7.66 (t, 1H, J = 7.3 Hz; H-p/p’), 7.56
(“t”, 2H, J = 7.6 Hz; H-m/m’), 7.54 (m, 1H; H-7), 7.52 (m, 1H; H-8), 7.49 (t, 1H, J = 7.3 Hz; H-p’/p), 7.43
(m, 2H; H-5’,6’), 7.41 (“t”, 2H, J = 7.3 Hz; H-m’/m), 5.55 (dd, 1H, J = 10.1, 2.9 Hz; H-2a), 4.36 (dd, 1H,
J = 17.4, 10.2 Hz; H-2b), 2.85 ppm (dd, 1H, J = 17.2, 2.6 Hz; H-2b); 13C-NMR (100 MHz, DMSO-d6):
δ = 198.58, 197.93(C-2b’, 2c), 159.67 (C-3), 156.92 (C-1), 152.93 (C-4a), 149.58 (C-2’), 148.62 (C-7a’), 146.99
(C-5a), 138.39 (C-3a’), 136.98, 136.37 (C-i, i’), 132.94, 132.49 (C-p, p’), 128.66, 128.41 (C-m, m’), 127.85,
127.55 (C-o, o’), 126.86, 126.53 (C-7, 9a), 125.41, 125.31, 125.24 (C-5’, 6’, 8), 123.86 (C-2), 118.38 (C-4’),
115.92 (C-9), 111.24 (C-6), 110.83 (C-7’), 103.22 (C-4), 39.5 (C-2a), 37.35 ppm (C-2b). MS (Fab, 70 eV, %):
m/z = 554 (M+, 40), 449 (25), 154 (100). Anal. Calcd. for C34H22N2O6 (554.15): C, 73.64; H, 4.00; N, 5.05.
Found: C, 73.69; H, 4.05; N, 5.11.
3.4. Crystal Structure Determinations
The single-crystal X-ray diffraction study were carried out on a Bruker D8 Venture diffractometer
(company, city, state abbr. if USA, country) with Photon100 detector at 123(2) K using Cu-Kα radiation
(λ = 1.54178 Å. Direct methods (SHELXS-97 for 6f) [30] or dual space/intrinsic methods (SHELXT
for 12) [31] were used for structure solution and refinement was carried out using SHELXL-2014
(full-matrix least-squares on F2; version, company, city, state abbr. if USA, country) [31]. Hydrogen
atoms were localized by difference electron density determination and refined using a riding model
(H(N,O)free). Semi-empirical absorption corrections were applied.
6f: colourless crystals, C26H21NO4, Mr = 411.44, crystal size 0.16 × 0.08 × 0.06 mm, triclinic,
space group P-1 (No. 2), a = 11.1823(3) Å, b = 14.3827(4) Å, c = 15.3460(4) Å, α = 67.695(1)◦,
β = 70.666(1)◦, γ = 68.389(1)◦, V = 2069.77(10) Å3, Z = 4, ρ = 1.320 Mg/m−3, µ(Cu-Kα) = 0.72 mm−1,
F(000) = 864, 2θmax = 144.2◦, 28,579 reflections, of which 8117 were independent (Rint = 0.035),
577 parameters, 5 restraints, R1 = 0.043 (for 6749 I > 2σ(I)), wR2 = 0.112 (all data), S = 1.01, largest diff.
peak/hole = 0.37/−0.50 e Å−3.
12: colourless crystals, C34H2N2O6, Mr = 554.53, crystal size 0.22 × 0.09 × 0.03 mm, triclinic,
space group P-1 (No. 2), a = 8.2672(2) Å, b = 11.3140(3) Å, c = 13.7326(3) Å, α = 91.721(1)◦,
β = 96.833(1)◦, γ = 92.198(1)◦, V = 1273.64(5) Å3, Z = 2, ρ = 1.446 Mg/m−3, µ(Cu-Kα) = 0.82
mm−1, F(000) = 576, 2θmax = 144.4◦, 18,981 reflections, of which 4987 were independent (Rint = 0.037),
382 parameters, 1 restraint, R1 = 0.048 (for 4212 I > 2σ(I)), wR2 = 0.127 (all data), S = 1.03, largest
diff. peak/hole = 0.35/−0.25 e Å−3.CCDC 1,913,026 (6f), and 1,913,027 (12) contain the supplementary
crystallographic data for this paper. These data can be obtained free of charge from The Cambridge
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
4. Conclusions
Reaction of 1,6-disubstituted-4-hydroxy-quinolin-2-ones with 2,3-dichloropyrazine, catalyzed by
triethylamine, furnished5:12-dihydropyrazino-[2,3-c:5,6-c′]difuro[2,3-c:4,5-c′]diquinoline-6,14(5H,12H)
-diones, by an apparent SNAr/ANRORC sequence. Reaction of the same quinolones with
(E)-dibenzoylethene led to conjugate addition without cyclization. Reaction of 2-hydroxyaniline
with diethyl malonate led unexpectedly to 4-(benzo-[d]oxazol-2-yl)-3-hydroxy-1H-[4,5]oxazolo-[3,2-
a]pyridine-1-one, which also underwent conjugate addition to dibenzoylethene.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/24/20/3782/s1,
Table S1. NMR spectroscopic data of compound 6f and Table S2. NMR spectroscopic data of compound 12.
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